A detailed history of Triasima Portfolio Management Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Triasima Portfolio Management Inc. holds 1,694 shares of REGN stock, worth $1.42 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,694
Holding current value
$1.42 Million
% of portfolio
0.2%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$883.2 - $1071.19 $1.5 Million - $1.81 Million
1,694 New
1,694 $1.78 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $89.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Triasima Portfolio Management Inc. Portfolio

Follow Triasima Portfolio Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Triasima Portfolio Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Triasima Portfolio Management Inc. with notifications on news.